TScan Therapeutics Stock (NASDAQ: TCRX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 365.11K |
Day Range | - - - |
52 Wk Range | 2.43 - 9.69 |
Market Cap | $292.42M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 3.57% |
Days to Cover | 6.63 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of TScan Therapeutics (NASDAQ:TCRX) through any online brokerage.
Other companies in TScan Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Tectonic Therapeutic (NASDAQ:TECX), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL) and PepGen (NASDAQ:PEPG).
TScan Therapeutics has a consensus price target of $11.40.
The stock price for TScan Therapeutics (NASDAQ: TCRX) is $5.52 last updated September 20, 2024 at 4:00 PM EDT.
A quarterly cash dividend of 0.42 per share of Class A Common Stock. The quarterly cash dividend was payable on June 30, 2018 to stockholders of record on June 14, 2018.
TScan Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for TScan Therapeutics.
TScan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.